Palantir price target raised to $255 from $215 at BofA

BofA raised the firm’s price target on Palantir (PLTR) to $255 from $215 and keeps a Buy rating on the shares. While others continue to push a “blue pill” option of generic, one-size-fits-most, Chat-GPT wrappers, Palantir’s “red pill” boot camps, an expensive software kit, an Ontology implementation path that prioritizes ROI, and the ability to scale with AI FDEs offers “a winning differentiated formula,” the analyst tells investors in a post-earnings note. The firm’s raised target reflects confidence in Palantir’s “enduring position and better than expected growth,” the analyst added.